Liver Transplant From Increased-Risk Donors in the Era of Direct-Acting Antivirals for Hepatitis C.
CONCLUSIONS: Increased-risk donor organs provided high levels of utility in liver transplant recipients who were anti-HCV positive, showing optimal graft and patient survival. Increased-risk donors were younger and preferably transplanted in hepatitis C virus RNA-positive recipients with lower Model for End-Stage Liver Disease score. Posttransplant direct-acting antiviral therapy was highly efficacious irrespective of pretransplant recipient and donor virologic status.
PMID: 31324136 [PubMed - as supplied by publisher]
Source: Experimental and Clinical Transplantation : official journal of the Middle East Society for Organ Transplantation - Category: Transplant Surgery Authors: Shaikh OS, Rogal S, Malik A, Sharma V, Cacciarelli T Tags: Exp Clin Transplant Source Type: research
More News: Antiviral Therapy | Epidemics | Epidemiology | Hepatitis | Hepatitis C | Hepatocellular Carcinoma | Kidney Transplant | Kidney Transplantation | Liver | Liver Cancer | Liver Disease | Liver Transplant | Middle East Health | Transplant Surgery | Transplants | Urology & Nephrology | Virology